Delivery Order SPE2DR25D7059-SPE2DR26F7MAM
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,800.72 to AmerisourceBergen Drug Corp for Timolol 0.25% gel-solution in 5ml quantities. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by October 29, 2025, just one day after the award date of October 28, 2025. The pharmaceutical product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Timolol 0.5% Gel-Solution in 5ml units, with a contract ceiling value of $4,887.48. This is a firm fixed price delivery order with an ultimate completion date of September 17, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide a pharmaceutical product, Timolol 0.5% GFS Gel-Solution 5ML, with a potential value of $1,224.59 and a completion date of February 27, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of up to $999,999,999.00...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Timolol 0.5% gel-solution in 5ml quantities. The award, valued at $8,263.10, has a completion date of February 23, 2024. Amerisourcebergen Drug Corp has received numerous similar awards from DLA Troop Support Medical to provide pharmaceuticals, medical supplies, and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,147.89, is for the delivery of TIMOLOL 0.25% GEL-SOLUTION 5ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 30, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the delivery of Timolol 0.5% Gel-Solution (5ml) to support government healthcare programs. The $14,197.90 delivery order was issued by the Defense Logistics Agency (DLA) and has a January 2022 completion date. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,309.28 firm fixed-price delivery order is for the supply of Timolol 0.5% Gel-Solution, a medication used for the treatment of eye conditions. The contract has a period of performance through January 31, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Timolol 0.5% Gel-Solution 5mL. The delivery order, valued at $15,888.80, is issued against an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that enables Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support...
- This federal contract award to AmerisourceBergen Drug Corp is a delivery order under a broader Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. The specific contract award is for $1,458.14 and covers the supply of Timolol 0.5% Gel-Solution, a medication used to treat glaucoma. This contract has no set-aside designation, indicating open competition. AmerisourceBergen, a major...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of Timolol 0.5% gel-solution, a pharmaceutical product used for the treatment of glaucoma. The contract has a ceiling value of $2,026.35 and a completion date of March 27, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation indicated. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- SPE2DR25D7059Indefinite Delivery Contract
- SPE2DR25D7059-SPE2DR26F7MAMDelivery Order
AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on November 17, 2025, for the supply of Timolol 0.5% Gel-Solution in 5ml units, with a contract ceiling value of $6,814.03. This is a firm fixed-price delivery order with no set-aside designation, completed competitively. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of November 18, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this prime contract vehicle. The DLA Troop Support Medical IDC enables the company to supply a broad portfolio of pharmaceutical products and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. The company's demonstrated capability to meet federal procurement requirements through open competition, evidenced by its consistent receipt of non-set-aside delivery orders, positions it as a key vendor within the military medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 11/17/25 |